QTLs in Region (mRatBN7.2)
631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat |
1578650 | Bmd6 | Bone mineral density QTL 6 | 12.2 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 1 | 509108 | 43284926 | Rat |
1354647 | Despr8 | Despair related QTL 8 | | 0.0000341 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 1 | 1 | 24744506 | Rat |
1578651 | Bmd7 | Bone mineral density QTL 7 | 14.2 | | femur mineral mass (VT:0010011) | compact volumetric bone mineral density (CMO:0001730) | 1 | 509108 | 43284926 | Rat |
2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat |
1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat |
2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
7421626 | Bp360 | Blood pressure QTL 360 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 4393289 | 49393289 | Rat |
2313070 | Bss52 | Bone structure and strength QTL 52 | 4.4 | 0.0001 | body length (VT:0001256) | body length (CMO:0000013) | 1 | 1 | 32356093 | Rat |
2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
631494 | Bp95 | Blood pressure QTL 95 | 40 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 16206210 | 49268520 | Rat |
2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat |
5684998 | Bss101 | Bone structure and strength QTL 101 | 3.6 | | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 1 | 15431621 | 49361612 | Rat |
2298546 | Neuinf4 | Neuroinflammation QTL 4 | 5.1 | | nervous system integrity trait (VT:0010566) | spinal cord RT1-B protein level (CMO:0002132) | 1 | 1 | 28736750 | Rat |
5684999 | Bss102 | Bone structure and strength QTL 102 | 5.5 | 7e-07 | tibia strength trait (VT:1000284) | tibia stiffness (CMO:0001735) | 1 | 15431621 | 49361612 | Rat |
1300167 | Hrtrt2 | Heart rate QTL 2 | 4.35 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 11481312 | 75088344 | Rat |
2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat |
2317755 | Glom22 | Glomerulus QTL 22 | 3.8 | | urine protein amount (VT:0005160) | urine protein level (CMO:0000591) | 1 | 11481482 | 32355910 | Rat |
1578756 | Iddm22 | Insulin dependent diabetes mellitus QTL 22 | 2.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 11835181 | 56835181 | Rat |
631508 | Sald1 | Serum aldosterone level QTL 1 | 3.7 | | blood aldosterone amount (VT:0005346) | serum aldosterone level (CMO:0000487) | 1 | 9856001 | 54856001 | Rat |
2313090 | Bmd69 | Bone mineral density QTL 69 | 4.4 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 1 | 32356093 | Rat |
4889451 | Eae29 | Experimental allergic encephalomyelitis QTL 29 | 5.51 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 1 | 5925877 | 24697545 | Rat |
724520 | Bp145 | Blood pressure QTL 145 | 2.1 | 0.0024 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 20784828 | 65784828 | Rat |
1558642 | Prcr2 | Prostate cancer resistance QTL 2 | 4.3 | | prostate integrity trait (VT:0010571) | area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) | 1 | 20763158 | 44095856 | Rat |
2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat |
2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
738020 | Pia8 | Pristane induced arthritis QTL 8 | 4.7 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 1 | 1 | 65833076 | Rat |
1600360 | Mcs16 | Mammary carcinoma susceptibility QTL 16 | 2.4 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 1 | 2244390 | 43433040 | Rat |
1578669 | Bss9 | Bone structure and strength QTL 9 | 6.3 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 1 | 509108 | 43284926 | Rat |
2302038 | Pia31 | Pristane induced arthritis QTL 31 | 5.5 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 1 | 10992065 | 55992065 | Rat |
634353 | Rends2 | Renal damage susceptibility QTL 2 | | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 1 | 19333571 | 56983283 | Rat |
2313053 | Bss51 | Bone structure and strength QTL 51 | 3.8 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 1 | 32356093 | Rat |